Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates

OBJECTIVES: The objective of this study was to evaluate the in vitro activity of CD101, a novel echinocandin with a long serum elimination half-life, and comparator (anidulafungin and caspofungin) antifungal agents against a collection of Candida and Aspergillus spp. isolates. METHODS: CD101 and com...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfaller, Michael A., Messer, Shawn A., Rhomberg, Paul R., Jones, Ronald N., Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031917/
https://www.ncbi.nlm.nih.gov/pubmed/27287236
http://dx.doi.org/10.1093/jac/dkw214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031917/
https://www.ncbi.nlm.nih.gov/pubmed/27287236
http://dx.doi.org/10.1093/jac/dkw214

Ejemplares similares